Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug–Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy
Dario Cattaneo, Luca Pasina, Aldo P. Maggioni, et al.
Drugs & Aging (2020) Vol. 37, Iss. 12, pp. 925-933
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
Omkar Indari, Shweta Jakhmola, E. Manivannan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 86
Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020)
Jesús Cebrino, Silvia Portero de la Cruz
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
Profil Antibiotik Pasien COVID-19 di RSUD Dr. Moewardi Surakarta
Rini Juni Astuti, Tri Murti Andayani
Generics Journal of Research in Pharmacy (2025) Vol. 5, Iss. 1, pp. 19-30
Open Access
Real-world studies: bridging the gap between trial-assessed efficacy and routine care
Daohong Chen
Journal of Biomedical Research (2022) Vol. 36, Iss. 3, pp. 147-147
Open Access | Times Cited: 18
Global prevalence of polypharmacy among the COVID-19 patients: a comprehensive systematic review and meta-analysis of observational studies
Hooman Ghasemi, Niloofar Darvishi, Nader Salari, et al.
Tropical Medicine and Health (2022) Vol. 50, Iss. 1
Open Access | Times Cited: 18
Individuals at risk for severe COVID-19 in whom ritonavir-containing therapies are contraindicated or may lead to interactions with concomitant medications: a retrospective analysis of German health insurance claims data
Christoph Lübbert, Igor Dykukha, Jann-Patrick Pelz, et al.
Drugs in Context (2023) Vol. 12, pp. 1-12
Open Access | Times Cited: 8
Pharmacology and Adverse Events of Emergency-Use Authorized Medication in Moderate to Severe COVID-19
Jen‐Yu Hsu, Yan–Chiao Mao, Po‐Yu Liu, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 955-955
Open Access | Times Cited: 18
Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases
Beatriz Oda Plasencia-García, María Isabel Rico-Rangel, Gonzalo Rodríguez-Menéndez, et al.
Pharmacopsychiatry (2021) Vol. 55, Iss. 01, pp. 40-47
Closed Access | Times Cited: 15
Drug–Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients
Dario Cattaneo, Luca Pasina, Aldo P. Maggioni, et al.
Drugs & Aging (2021) Vol. 38, Iss. 4, pp. 341-346
Open Access | Times Cited: 12
Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system
Eugene Jeong, Scott D. Nelson, Yu Su, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data
Levin Thomas, Sumit Birangal, Rajdeep Ray, et al.
Therapeutic Advances in Drug Safety (2021) Vol. 12
Open Access | Times Cited: 9
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study
Pia Clara Pafundi, Raffaele Galiero, Vittorio Simeon, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0256903-e0256903
Open Access | Times Cited: 9
Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics and System Biology Analyses: The Role of Pregnane X Receptor
Jingjing Huang, Zhaokang Zhang, Chenxia Hao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Potentially inappropriate medications based on TIME criteria and risk of in-hospital mortality in COVID-19 patients
Nurdan Şentürk Durmuş, Aslı Tufan, Büşra Can, et al.
Revista da Associação Médica Brasileira (2022) Vol. 68, Iss. 12, pp. 1730-1736
Open Access | Times Cited: 6
Tools supporting polypharmacy management in Italy: Factors determining digital technologies' intention to use in clinical practice
Elisabetta Catrini, Lucrezia Ferrario, Antonino Mazzone, et al.
Health Science Reports (2022) Vol. 5, Iss. 3
Open Access | Times Cited: 4
Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients
Türkan Paşalı Kilit, Filiz Özyiğit, Sertaş Erarslan, et al.
African Health Sciences (2022) Vol. 22, Iss. 4, pp. 597-606
Open Access | Times Cited: 4
Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience
Dario Cattaneo, Luca Pasina, Federico Conti, et al.
Journal of Endocrinological Investigation (2021) Vol. 44, Iss. 12, pp. 2849-2851
Open Access | Times Cited: 4
Impact of preemptive hospitalization on health outcomes at the temporary COVID-19 hospital in Mexico City: a prospective observational study
Rafael Ricardo Valdez Vázquez, Héctor Gallardo‐Rincón, Julieta Lomelín‐Gascón, et al.
Therapeutic Advances in Infectious Disease (2021) Vol. 8
Open Access | Times Cited: 4
COVID-19 drugs: potential interaction with ATP-binding cassette transporters P-glycoprotein and breast cancer resistance protein
Jaeok Lee, Jihye Kim, Jiyeon Kang, et al.
Journal of Pharmaceutical Investigation (2022) Vol. 53, Iss. 2, pp. 191-212
Open Access | Times Cited: 3
Drug–Drug Interactions of Hydroxychloroquine and Chloroquine in Older Patients with COVID-19 during the First Pandemic Waves: The GeroCovid Observational Study
Caterina Trevisan, Andrea Cignarella, Andrea Grandieri, et al.
Reports — Medical Cases Images and Videos (2024) Vol. 7, Iss. 2, pp. 42-42
Open Access
IPNA clinical practice recommendations on care of pediatric patients with pre-existing kidney disease during seasonal outbreak of COVID-19
Khalid Alhasan, Rupesh Raina, Olivia Boyer, et al.
Pediatric Nephrology (2024)
Open Access
The role of INTERCheckWEB digital innovation in supporting polytherapy management
Emanuela Foglia, Lucrezia Ferrario, Elisabetta Garagiola, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Potential drug-drug interactions and their associated factors in hospitalized COVID-19 patients with comorbidities
Imanda Rahmadani, Sylvi Irawati, Yosi Irawati Wibowo, et al.
PeerJ (2023) Vol. 11, pp. e15072-e15072
Open Access | Times Cited: 1
Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN
Antonio Martocchia, Clara Bruscia, Giulia Conforti, et al.
SN Comprehensive Clinical Medicine (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 2
Peer Review #1 of "Potential drug-drug interactions and their associated factors in hospitalized COVID-19 patients with comorbidities (v0.2)"
Imanda Rahmadani, Sylvi Irawati, Yosi Irawati Wibowo, et al.
(2023)
Open Access
Page 1 - Next Page

Scroll to top